Xeris Biopharma Holdings, Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6 7
Rok finansowy 2016 2017 2018 2019 2021 2022 2023 2024
Przychód (mln) 1 2 2 20 50 110 110 164
Przychód Δ r/r 0.0% 44.7% 58.4% 717.6% 146.0% 122.3% 0.0% 48.7%
Marża brutto 99.3% 99.7% 98.3% 53.7% 73.1% 79.5% 79.5% 75.9%
EBIT (mln) -13 -27 -59 -84 -115 -82 -82 -44
EBIT Δ r/r 0.0% 101.3% 122.9% 40.8% 37.8% -28.8% 0.0% -46.3%
EBIT (%) -1230.8% -1711.4% -2407.5% -414.5% -232.2% -74.3% -74.3% -26.8%
Koszty finansowe (mln) 0 0 3 11 7 15 15 27
EBITDA (mln) -13 -26 -57 -118 -115 -71 -71 -31
EBITDA(%) -1220.0% -1692.1% -2342.0% -399.8% -231.1% -64.5% -64.5% -18.8%
Podatek (mln) -0 0 2 -0 -0 -1 -1 -1
Zysk Netto (mln) -13 -27 -60 -91 -123 -95 -95 -62
Zysk netto Δ r/r 0.0% 101.0% 126.3% 51.7% 34.7% -22.9% 0.0% -34.2%
Zysk netto (%) -1228.7% -1706.6% -2437.3% -452.2% -247.5% -85.9% -85.9% -38.0%
EPS -7.17 -13.09 -4.99 -3.49 -2.88 -1.2 -0.7 -0.45
EPS (rozwodnione) -7.17 -13.09 -4.99 -3.49 -2.88 -1.2 -0.7 -0.45
Ilośc akcji (mln) 2 2 12 26 43 79 136 138
Ważona ilośc akcji (mln) 2 2 12 26 43 79 136 138
Waluta USD USD USD USD USD USD USD USD